Compare VYX & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VYX | IART |
|---|---|---|
| Founded | 1881 | 1989 |
| Country | United States | United States |
| Employees | 13500 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 980.9M | 1.2B |
| IPO Year | N/A | 1996 |
| Metric | VYX | IART |
|---|---|---|
| Price | $7.87 | $18.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 7 |
| Target Price | $13.67 | ★ $14.33 |
| AVG Volume (30 Days) | ★ 2.5M | 874.6K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.39 |
| Revenue Next Year | N/A | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.02 | $8.70 |
| 52 Week High | $14.67 | $18.53 |
| Indicator | VYX | IART |
|---|---|---|
| Relative Strength Index (RSI) | 62.20 | 68.78 |
| Support Level | $6.29 | $10.61 |
| Resistance Level | $8.41 | N/A |
| Average True Range (ATR) | 0.49 | 0.71 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 80.19 | 91.01 |
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.